Science & Co Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.4/10

Best for: flat any-dose compounded semaglutide or tirzepatide, if you can prepay a 12-month plan

8.4
★★★★4.2/5

What Science & Co does best is charge less than most of the register.

$79/mo

charged as a multi-month plan up front

Same price at every dose

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

Science & Co is a telehealth platform run by Science and Co, Inc., a Delaware corporation with a Miami mailing address, selling compounded semaglutide and tirzepatide prescribed by an affiliated provider group. The price stays the same at every dose. Plans are advertised from $79/mo for semaglutide and $125/mo for tirzepatide, both on the 12-month plan, which the site says is paid upfront; the month-to-month price is not shown on its public pages.

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GLP-1 from $79/moPrice shown up frontFlat across dosesIncludes medication + consultNo FDA letter on record

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

Vetted alternatives to Science & Co

9.3/ 10
Verified partner

He & She MD

Best for: starting below a standard dose, with microdose tiers

★★★★4.7/5

Editorial score · methodology

99/mo
CompoundedSemaglutideTirzepatideLegitScript Verified
Get StartedRead full He & She MD review →
6.0/ 10
Verified partner

Wellorithm

Best for: compounded semaglutide at $247/month

★★★☆☆3/5

Editorial score · methodology

147/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Wellorithm review →
6.9/ 10
Verified partner

MyDrHank

Best for: an oral route if you will not self-inject

★★★3.5/5

Editorial score · methodology

171/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full MyDrHank review →
Science & Co
4.2 / 5
Our editorial rating
Visit Science & Co

from $79/mo · no insurance needed

Science & Co at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide
Starting price
$79/mo (Science & Co advertises plans from $79 a month on its 12-month plan, about $2 a day, beside a struck-through $149. It...)
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult · Shipping
FDA status
No FDA warning letter on record

How Science & Co scores

Six columns, each one computed from something Science & Co has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.

Value25%

10.0/10

$79/month is 58% below the register median of $189 for compounded semaglutide. ⚠ That figure is a multi-month plan charged up front, not a month-to-month rate, so it is not like-for-like against the median.

Effectiveness25%

10.0/10

Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).

User Experience15%

8.0/10

On the seller's own pages, a price is published before the questionnaire starts.

Trust & Safety15%

6.5/10

does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is medium.

Accessibility10%

5.0/10

Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.

Support10%

7.0/10

The price covers medication, consult, shipping.

6weighted dimensions
588sellers in the register
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →

What we checked on Science & Co

Last checked September 2026
  • Re-read the price on file across 2 dose or plan tiers
  • Checked state coverage: all 50
  • Established what the monthly figure covers, and what it leaves out
  • Searched our FDA enforcement register for this operator

Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: medium.

What signing up with Science & Co involves

Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.

  1. 1Science & Co publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
  2. 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
  3. 3Science & Co does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
  4. 4The monthly price is recorded as covering medication, consult, shipping.
Price shown before you start
  • Cheapest standing monthly prices on record: semaglutide $79, tirzepatide $125. Membership fees, first-month rates and insured copays are excluded from those figures.
  • No state list is published, so whether Science & Co serves your state cannot be confirmed from its site.
  • The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.

Science & Co support, as documented

Cancelling Science & Co

Read from what Science & Co publishes in its own terms. Where a line says the seller does not publish something, that is the finding — we looked and it is not stated. Terms change; check the seller’s current policy before you subscribe.

Cancel any time
Yes
Minimum commitment
Plan length is chosen at checkout; the advertised price is the 12-month plan, which is paid upfront. Cancel or pause at least 72 hours before the next processing date.
Refund policy
"all sales of prescription medication are final" once the order is charged and handed to the carrier
Early-termination fee
None

GLP-1 medications Science & Co offers

Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.

Pricing

Prices re-verified

Weekly injection, 12-month plan (per-month rate, same at every dose)Compounded
$79/mo
semaglutide

Science & Co advertises plans from $79 a month on its 12-month plan, about $2 a day, beside a struck-through $149. It says multi-month plans are paid upfront for the full term, so the year comes to about $948 in one charge. The month-to-month price is not listed on the public pages.

Weekly injection, 12-month plan (per-month rate, same at every dose)Compounded
$125/mo
tirzepatide

Advertised from $125 a month on the 12-month plan, about $4 a day, beside a struck-through $199. Multi-month plans are paid upfront for the full term, so the year comes to about $1,500 in one charge. The month-to-month price is not listed on the public pages.

Check the price yourself before you pay

Every figure here was read off Science & Co's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.

See Science & Co pricing →

In its favor

  • Semaglutide at $79 a month, 58% below the $189 median for the same drug and form across this register
  • Tirzepatide at $125 a month, 52% below the $259 median for the same drug and form across this register
  • Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
  • The monthly price is recorded as flat across doses, so it does not climb as the dose is titrated up
  • The monthly figure covers medication, consult, shipping
  • No FDA warning letter matched this operator when we searched our enforcement register

Against it

  • No state list is on record here, so whether it serves your state cannot be confirmed from this page
  • No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

What Science & Co charges

Science & Co charges $79/month, and holds that rate across every dose. That sits at the affordable end of what we track. Flat dose pricing matters more than it reads: on a tiered plan the bill grows as the dose does, which means the figure that persuaded you to sign up is not the figure you end up living with.

  • Compounded semaglutide — $79/month
  • Compounded tirzepatide — $125/month

Across the GLP-1 providers in our register the median standing price is about $170/month, so Science & Co is genuinely under the middle rather than merely advertising that it is.

Embody, at about $79/month, is the closest thing we track to a like-for-like alternative.

What Science & Co dispenses

Science & Co prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.

What we could verify

On the record: it treats patients in all 50 states. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.

Who should look elsewhere

  • You want the FDA-approved pen specifically. Nothing here is the approved finished product.
  • You need to bill insurance. Like most of this market, this is cash-pay.

It fits if

  • the lowest standing monthly cost is what you are solving for
  • you want the price to stop moving as your dose climbs
  • you need access regardless of where you live

Our read

Science & Co competes on price and does it without an obvious sacrifice elsewhere: $79/month, no warning letter on file, and access that is not unusually restricted.

The Bottom Line

What Science & Co does best is charge less than most of the register.

Score: 8.4/10Best for: flat any-dose compounded semaglutide or tirzepatide, if you can prepay a 12-month planFrom: $79/mo

Before you pay Science & Co

Starting at $79 a month. Check today's price, then book the free consultation.

Where Science & Co is the wrong choice

No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.

  • If you need the FDA-approved pen rather than a compounded vial, consider Gala.
  • If the standing monthly cost is what decides it, consider Collective (from $59/mo).
  • If you want a human checking in, not just a prescription, consider He & She MD.

Frequently Asked Questions

Science & Co is a telehealth platform run by Science and Co, Inc., a Delaware corporation with a Miami mailing address, selling compounded semaglutide and tirzepatide prescribed by an affiliated provider group. The price stays the same at every dose. Plans are advertised from $79/mo for semaglutide and $125/mo for tirzepatide, both on the 12-month plan, which the site says is paid upfront; the month-to-month price is not shown on its public pages. Our six-dimension score for it is 8.4/10.
Science & Co is a real, operating US company. We checked its posted prices and what it sells against its own site, and the register scores it 8.4/10 on six dimensions. A score is a finding about the seller. It is not advice about you.
Science & Co starts at $79 a month. That number holds across doses, so titrating up does not move the bill. The pricing table above carries every tier we have on record.
Science & Co publishes no promo or coupon code. Its $79 a month is the cash price, and there is nothing to apply a code against. Sites advertising "Science & Co discount codes" are not a source we verify. Any live offer applies without a code.
Science & Co says it treats patients in all 50 states.
Science & Co sells semaglutide (sold as Wegovy and Ozempic) and tirzepatide (sold as Zepbound and Mounjaro). Every dose it lists is compounded.
Science & Co lists compounded GLP-1s only. A licensed compounding pharmacy prepares them: same active ingredient as the brand drug, lower cash price, and no FDA approval of the finished product. That last part is the one readers underestimate, and the review above says why.
Science & Co is cash only. No insurance enters the transaction, and FSA and HSA cards are accepted.
Science & Co says the price covers medication, the clinician visit and shipping. The strip near the top of this review shows what we could confirm and what the seller leaves unstated.
You fill in an online intake, a licensed clinician decides whether a GLP-1 is appropriate, and if the answer is yes the medication ships to you. Science & Co runs that whole sequence on its own site.
No FDA action sits against Science & Co in our record. What we flag instead is mostly disclosure: No state list is on record here, so whether it serves your state cannot be confirmed from this page; No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here; Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality. None of those is a safety finding. All of them are things worth pricing in before you buy.

Glossary

The words sellers use, defined. Tap any term.

Sources

Cited across this Science & Co review: primary regulatory filings, and peer-reviewed studies.

Sources & methodology — as of September 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDAU.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDAU.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)New England Journal of Medicine.PMID: 40334173.

See Science & Co's current pricing

Plans start at $79 a month. The free consultation is where you learn whether you qualify, and what it costs today.